[Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding]

Ostensen, M (2006). [Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding]. Zeitschrift für Rheumatologie, 65(3), 217-20, 222. Heidelberg: Steinkopff-Verlag 10.1007/s00393-006-0052-5

Preview

Text 393_2006_Article_52.pdf - Published Version Available under License Publisher holds Copyright. Download (674kB) | Preview

Antirheumatic drugs can have a negative effect on reproduction in both men and women. Possible negative effects are impairment of fertility, harmful effects on the fetus and adverse effects on the breastfed child. In women non-steroidal antiinflammatory drugs (NSAID) and cyclophosphamide can impair fertility. In men infertility can result from the use of salazopyrine and cyclophosphamide. A desire for children should be taken into account before the start of disease modifying drugs (DMARD). Treatment with NSAID is possible at some stages of pregnancy as well as during lactation. A limited number of DMARD is compatible with pregnancy and is presented. Cytostatic drugs and leflunomide must be prophylactically withdrawn before a planned pregnancy. TNF alpha antagonists should be discontinued at the start of pregnancy. Safe birth control must be practised during therapy with drugs that are gonadotoxic or teratogenic. Treatment with immunosuppressive drugs during lactation is limited because of insufficient documentation of safety for the breastfed child.

Interest & Impact

Downloads

414 since deposited on 04 Oct 2013
102 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item